Parkinson's Disease Clinical Trial
Official title:
A Pilot Study of the Effects of Balance Training Using the Wii Balance Board on Balance and Ambulation in Adults With Parkinson's Disease
The purpose of this study is to assess the facilitation of balance in Parkinson's disease (PD) patients using the Nintendo Wii fit, with the ultimate goal of developing a program for function and fitness in this patient population. In this study, PD patients will participate in group exercise classes using the Wii Fit and the effects on balance, postural sway, and quality of life assessed.
Status | Completed |
Enrollment | 10 |
Est. completion date | February 2011 |
Est. primary completion date | November 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Adult, 18 years or greater 2. The patient is able to provide informed consent. 3. Definitive Idiopathic Parkinson's Disease as diagnosed by a Neurologist 4. Hoehn and Yahr Stage 2.5-3 5. Able to ambulate at least 150 ft without an assistive device per patient report 6. On stable doses of Parkinson's medications for at least 2 weeks prior to study onset 7. Endurance sufficient to stand at least 20 minutes unassisted per patient report Exclusion Criteria: 1. Mini Mental Status Exam (MMSE) < 24 2. Anticipated change in Parkinson's medications in the duration of study 3. Uncontrolled orthostasis 4. Symptomatic coronary artery disease 5. Fracture of lower limb within 6 months prior to study onset 6. Other neurologic diagnosis, including Multiple Sclerosis 7. Other vestibular disease 8. Untreated severe depression (depression of greater than or equal 20 on the Geriatric Depression Scale) 9. Acute illness 10. History of, or current, alcohol abuse 11. Significant visual impairment that would inhibit ability to participate in study, with distance vision >20/40 12. Drug induced or inherited Parkinson's Disease 13. Physical therapy within the month prior to study entry 14. Use of the Wii balance board at home as an exercise program 15. Significant camptocormia 16. Physical Therapy during the study duration 17. Any medical condition which the physician investigator determines would compromise the safety of exercise program for the subject. |
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Rehabilitation Institute of Chicago | Chicago | Illinois |
Lead Sponsor | Collaborator |
---|---|
Rehabilitation Institute of Chicago |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Berg Balance Scale | 8 weeks | Yes | |
Secondary | Dynamic Gait Index | 8 weeks | Yes | |
Secondary | Parkinson's Disease QOL Questionnaire (PDQ-8) | 8 weeks | No | |
Secondary | Postural Sway | 8 weeks | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02874274 -
Vaccination Uptake (VAX) in PD
|
N/A | |
Terminated |
NCT02924194 -
Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease
|
N/A |